Metraipolis › archive › dc_609a35f7e6e2

Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors — Europe PMC PMID:41347170

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41347170
DOI
10.3389/fphar.2025.1696229
License (as archived)
solo-consultazione
Archived
2026-11-08T10:21:07.713Z
SHA-256 of the archived text
b79518d0b5abf9bf82e431fdd55b799dda0df631174229f41974a8f6de03c747
Stable URL of this page
https://metraipolis.com/documento/dc_609a35f7e6e2

How to cite

Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors — Europe PMC PMID:41347170 — Europe PMC (en), https://europepmc.org/article/MED/41347170 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_609a35f7e6e2 (Metraipolis archive dc_609a35f7e6e2, sha256 b79518d0b5abf9bf82e431fdd55b799dda0df631174229f41974a8f6de03c747)
BibTeX
@misc{dc609a35f7e6e2,
  title = {Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors — Europe PMC PMID:41347170},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41347170},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_609a35f7e6e2; sha256 b79518d0b5abf9bf82e431fdd55b799dda0df631174229f41974a8f6de03c747},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41347170. Agents can read the archived copy with the MCP tool read_document.